Skip to main content
. 2012 Jul;8(4):253–259. doi: 10.1200/JOP.2012.000578

Table 1.

Demographic and Clinical Characteristics of Study Cohort (N = 1,151)

Characteristic Colon (n = 657)
Rectal (n = 494)
No. % No. %
Age at diagnosis, years
    < 50 40 6.1 41 8.3
    50-64 168 25.6 170 34.4
    65-74 183 27.9 130 26.3
    ≥ 75 266 40.5 153 31.0
    Mean 69.6 67.0
    SD 12.1 12.4
Sex
    Female 353 53.7 174 35.2
    Male 304 46.3 320 64.8
Collaborative stage at diagnosis
    IIA 176 35.6
    IIB 90 13.7 41 8.3
    IIIA 47 7.2 37 7.5
    IIIB 357 54.3 146 29.6
    IIIC 163 24.8 94 19.0
District health authority
    With tertiary care center 359 54.6 279 56.5
    Without tertiary care center 298 45.4 215 43.5
Residential location
    Urban 423 64.4 322 65.2
    Rural 226 34.4 167 33.8
    Unknown 8 1.2 5 1.0
Social deprivation index, quintile
    0 (most deprived) 117 17.8 92 18.6
    1 148 22.5 105 21.3
    2 131 19.9 96 19.4
    3 133 20.2 101 20.4
    4 (least deprived) 124 18.9 99 20.0
    Unknown 4 0.6 1 0.2
Material deprivation index, quintile
    0 (most deprived) 144 21.9 104 21.1
    1 140 21.3 95 19.2
    2 139 21.2 120 24.3
    3 130 19.8 101 20.4
    4 (least deprived) 100 15.2 73 14.8
    Unknown 4 0.6 1 0.2
Elixhauser comorbidity score
    0 359 54.6 351 71.1
    1 145 22.1 74 15.0
    ≥ 2 153 23.3 69 14.0
No. of previous primary cancers (any type)
    0 546 83.1 457 92.5
    1 95 14.5 34 6.9
    ≥ 2 16 2.4 3 0.6
Surgical presentation
    Emergency 192 29.2 29 5.9
    Elective 459 69.9 460 93.1
    Unknown 6 0.9 5 1.0
No. of lymph nodes examined
    < 12 373 56.8 322 65.2
    ≥ 12 260 39.6 162 32.8
    Unknown 24 3.7 10 2.0
Length of stay for hospital admission, days
    Mean 17.9 14.8
    SD 20.7 14.5
Readmission within 30 days 63 9.6 72 14.6
Chemotherapy use
    Receipt of medical oncology consultation 494 75.2 398 80.6
    Receipt of chemotherapy 363 55.3 316 64.0
    Meeting the 12-week benchmark (for those receiving chemotherapy) 286 78.8 211 66.8

Abbreviation: SD, standard deviation.